Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels.

ABSTRACT:

Background

Patients with heart failure (HF) are reportedly at high risk for 'all-cause' re-hospitalization. A biomarker for HF, N-terminal pro-brain natriuretic peptide (NT-proBNP), enables to simply detect patients with possible HF (pHF). We examined the hospitalization and medical cost of Japanese patients detected by an elevated serum NT-proBNP, and also evaluated the effects of institutional team approaches for HF on their all-cause hospitalizations.

Methods

We retrospectively extracted all adult patients with serum NT-proBNP ≥400 pg/ml measured between January and March 2012 in Hiroshima University Hospital as pHF-positive patients. We studied their all-cause hospitalization records during the past 3-year period. We also extracted all pHF-negative patients with NT-proBN

SUBMITTER: Kitagawa T 

PROVIDER: S-EPMC5755927 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature